The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Whole-body positron emission tomography using fluorodeoxyglucose for staging of lymphoma: effectiveness and comparison with computed tomography
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
UPDATED KIEL CLASSIFICATION FOR LYMPHOMAS
Stansfeld, A. G., Diebold, J., Kapanci, Y., Kelényi, G., Lennert, K., Mioduszewska, O., Noel, H., Rilke, F., Sundstrom, C., Van Unnik, J. A. M., et al. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90367-4 · Cited by 1,149
Huerta, G. T., & Villasana, J. E. M. (1988) · PubMed · Cited by 804
Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose
Rigo, P., Paulus, P., Kaschten, B. J., Hustinx, R., Bury, T., Jerusalem, G., Benoit, T., & Foidart-Willems, J. (1996) · European Journal of Nuclear Medicine · doi:10.1007/bf01249629 · Cited by 501
Steinert, H. C., Hauser, M., Allemann, F., Engel, H., Berthold, T., von Schulthess, G. K., & Weder, W. (1997) · Radiology · doi:10.1148/radiology.202.2.9015071 · Cited by 376
Self-citationWhole-body FDG-PET imaging for staging of Hodgkin's disease and lymphoma.
Hoh, C. K., Glaspy, J. A., Rosen, P., Dahlbom, M. L., Lee, S. J., Kunkel, L., Hawkin, R. A., Maddahi, J., & Phelps, M. E. (1997) · PubMed · Cited by 274
Okada, J., Yoshikawa, K., Itami, M., Imaseki, K., Uno, K., Itami, J., Kuyama, J., Mikata, A., & Arimizu, N. (1992) · PubMed · Cited by 218
Steinert, H. C., Böni, R. A. H., Buck, A., Böni, R., Berthold, T., Marinček, B., Burg, G., & von Schulthess, G. (1995) · Radiology · doi:10.1148/radiology.195.3.7753998 · Cited by 193
Self-citationPaul, R. (1987) · PubMed · Cited by 149
The significance of the residual mediastinal mass in treated Hodgkin's disease.
Jochelson, M., Mauch, P., Balikian, J., Rosenthal, D. N., & Canellos, G. (1985) · Journal of Clinical Oncology · doi:10.1200/jco.1985.3.5.637 · Cited by 141
Hoekstra, O. S., Ossenkoppele, G. J., Golding, R. P., van Lingen, A., Visser, G. W. M., Teule, G. J. J., & Huijgens, P. C. (1993) · PubMed · Cited by 108
Cited by
Revised Response Criteria for Malignant Lymphoma
Cheson, B. D., Pfistner, B., Juweid, M. E., Gascoyne, R. D., Specht, L., Horning, S. J., Coiffier, B., Fisher, R. I., Hagenbeek, A., Zucca, E., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.2403 · Cited by 4,426
(2001) · PubMed · Cited by 943
Clinical Applications of PET in Oncology
Rohren, E. M., Turkington, T. G., & Coleman, R. E. (2004) · Radiology · doi:10.1148/radiol.2312021185 · Cited by 859
Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development
Kelloff, G. J., Hoffman, J. M., Johnson, B., Scher, H. I., Siegel, B. A., Cheng, E. Y., Cheson, B. D., O'Shaughnessy, J., Guyton, K. Z., Mankoff, D. A., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2626 · Cited by 671
Integrated PET/CT: Current Applications and Future Directions
von Schulthess, G. K., Steinert, H. C., & Hany, T. F. (2006) · Radiology · doi:10.1148/radiol.2382041977 · Cited by 619
Self-citationSpaepen, K., Stroobants, S., Dupont, P., Van Steenweghen, S., Thomas, J., Vandenberghe, P., Vanuytsel, L., Bormans, G., Balzarini, J., De Wolf-Peeters, C., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.2.414 · Cited by 465
Utility of FDG-PET scanning in lymphoma by WHO classification
Elstrom, R., Guan, L., Baker, G., Nakhoda, K., Vergilio, J.-A., Zhuang, H., Pitsilos, S., Bagg, A., Downs, L., Mehrotra, A., et al. (2003) · Blood · doi:10.1182/blood-2002-09-2778 · Cited by 437
Clinical Role of FDG PET in Evaluation of Cancer Patients
Kostakoglu, L., Agress, H., & Goldsmith, S. J. (2003) · RadioGraphics · doi:10.1148/rg.232025705 · Cited by 402
18F-FDG PET/CT Imaging In Oncology
Almuhaideb, A., Papathanasiou, N., & Bomanji, J. (2011) · Annals of Saudi Medicine · doi:10.4103/0256-4947.75771 · Cited by 388
Blodgett, T. M., Meltzer, C. C., & Townsend, D. W. (2007) · Radiology · doi:10.1148/radiol.2422051113 · Cited by 387
Bar-Shalom, R., Valdivia, A. Y., & Blaufox, M. D. (2000) · Seminars in Nuclear Medicine · doi:10.1053/snuc.2000.7439 · Cited by 340
Positron Emission Tomography Scanning: Current and Future Applications
Czernin, J., & Phelps, M. E. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.104028 · Cited by 328
PET Diagnostic Accuracy: Improvement with In-Line PET-CT System: Initial Results
Hany, T. F., Steinert, H. C., Goerres, G. W., Buck, A., & von Schulthess, G. K. (2002) · Radiology · doi:10.1148/radiol.2252011568 · Cited by 323
Self-citationThe role of FDG-PET scans in patients with lymphoma
Seam, P., Juweid, M. E., & Cheson, B. D. (2007) · Blood · doi:10.1182/blood-2007-06-097238 · Cited by 304
Jerusalem, G., Beguin, Y., Najjar, F., Hustinx, R., Fassotte, M. F., Rigo, P., & Fillet, G. (2001) · Annals of Oncology · doi:10.1023/a:1011169332265 · Cited by 268
Infection imaging using whole-body FDG-PET
Stumpe, K. D. M., Dazzi, H., Schaffner, A., & von Schulthess, G. K. (2000) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590000277 · Cited by 266
Self-citationImaging in staging of malignant lymphoma: a systematic review
Kwee, T. C., Kwee, R. M., & Nievelstein, R. A. J. (2008) · Blood · doi:10.1182/blood-2007-07-101899 · Cited by 264
Metadata
- Authors
- Stumpe, K. D. M., Urbinelli, M., Steinert, H. C., Glanzmann, C., Buck, A., & von Schulthess, G. K.
- Venue
- European Journal of Nuclear Medicine and Molecular Imaging
- Published
- 1998-07-17
- Volume
- 25
- Issue
- 7
- Pages
- 721-728
- ISSN
- 1619-7070 (ISSN-L)
- 1619-7089
- OpenAlex
- W2012324903
- Cited by
- 261
- References
- 12
- FWCI
- 12.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.